Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

AR-301 gets FDA fast track designation for acute pneumonia caused by S. aureus

Sep. 14, 2015

New approaches identified for Middle-East respiratory syndrome coronavirus vaccination

Sep. 14, 2015

New antimalarial classes discovered at the Walter Reed Army Institute

Sep. 10, 2015

Canadian funding for VBI Vaccines' development of RSV vaccine

Sep. 10, 2015

GeoVax's Ebola vaccine shows efficacy in rodent models

Sep. 10, 2015

Topline results from phase III IGNITE2 study of eravacycline for cUTI

Sep. 9, 2015

Biodim presents bacterial dltA inhibitors

Sep. 9, 2015

Basilea Pharmaceutica's BAL-30072 will be part of European iABC program

Sep. 8, 2015

Tetraphase's TP-271 receives FDA QIDP and fast track designations

Sep. 4, 2015

FDA grants fast track designation to intravenous iclaprim

Sep. 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...